2Morachiello P,Landini S,Rracasso A,Combined hemo dialysis-hemoperfusion in the treatment of secondary hyperparathyroidism of uremic[J].Blood Purif,1991 ,9(3):148.
3Klassen PS,Lawrin G,Reddan DN,et al.Association between pulse pressure and morta1ity in patients undergoing maintenance hemodialysis[].The Journal of The American Medical Association.2002
4Block GA,Port FK.Re-evaluation of risks associated with hy-perphosphatemia and hyperparathyroidsm in dialysis patients:Recommendations for a change in management[].American Journal of Kidney Diseases.2000
5Dubel JR,Milford EL.The relationship between serum calcium and phosphate levels and cardiac valvular procedures in the hemo-dialysis population[].American Journal of Kidney Diseases.2003
6Duerin AP,London GM,Marchais SJ,et al.Arterial stiffening and vascular calcifications in end-stage renal disease[].Nephrology Dialysis Transplantation.2000
7TzannoMartins C,Futata E,Jorgetti V,et al.Immune re-sponse in hemodialysis patients:is there any difference when low and high iPTH levels are compared?[].Clinical Nephrology.2000
8Ganesh SK,Stack AG,Levin NW,et al.Association of elevat-ed serum P04,Cax P04product,and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients[].JAS-NL.2001
9Fuarles LD,Sherrard DJ,Adler S,et al.The calcimimetic AMG073as a potential treatment for secondary hyperparathyroid-ism of end-stage renal disease[].Journal of the American Society of Nephrology.2003
10Blacher J,Guerin AP,Pannier B,et al.Arterial calcifications,arterial stiffness,and cariovascular risk in end-stage renal dis-ease[].Journal of Hypertension.2001
